Dose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humans

A. Polleri, P. Masturzo, G. Murialdo, A. Carolei

Research output: Contribution to journalArticlepeer-review

Abstract

Single doses of carbidopa and benserazide, two inhibitors of aromatic aminoacids decarboxylase, have been given orally to healthy women and men aged 19 to 32 years. Serum prolactin levels increased in respect to baseline levels when 80, 125 or 250 mg of carbidopa and 10, 20, 30, 80 or 125 mg of benserazide were given. The carbidopa doses of 20 and 50 mg were ineffective. Carbidopa induced the enhancement of serum prolactin at a later time and over a longer time span than benserazide. The effect on serum prolactin is dose dependent for both drugs. The hyperprolactinaemia obtained with 250 mg of carbidopa and with 125 mg of benserazide is significantly larger in women than in age matched men. The observed prolactin increase fits with the hypothesis that a diminution of the inhibitory effect of dopamine at the pituitary and/or at the median eminence levels may occur in connection to the pharmacologically impaired monoamine synthesis. An effect of serotonin cannot, however, be excluded.

Original languageEnglish
Pages (from-to)7-12
Number of pages6
JournalActa Endocrinologica
Volume93
Issue number1
Publication statusPublished - 1980

ASJC Scopus subject areas

  • Endocrinology

Fingerprint Dive into the research topics of 'Dose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humans'. Together they form a unique fingerprint.

Cite this